Loading insider details...
Beta
Latest Form 4 (Sep 29, 2026): Exercise/Conversion of 4,629 CHE shares, $2.06M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 29, 2026 | CHEMED CORP (CHE) | Exercise/Conversion | 4,629 | $2.06M |
| Feb 17, 2026 | CHEMED CORP (CHE) | Exercise/Conversion | 199 | $93.4K |
| Oct 22, 2025 | CHEMED CORP (CHE) | Grant/Award | 6,338 | $2.81M |
| Feb 18, 2025 | CHEMED CORP (CHE) | Exercise/Conversion | 315 | $174.3K |
| Oct 23, 2024 | CHEMED CORP (CHE) | Grant/Award | 4,523 | $2.70M |
| Aug 9, 2024 | CHEMED CORP (CHE) | Sale | 4,827 | $2.78M |
| Mar 7, 2024 | CHEMED CORP (CHE) | Exercise/Conversion | 1,267 | $523.5K |
| Feb 20, 2024 | CHEMED CORP (CHE) | Exercise/Conversion | 84 | $49.3K |
| Nov 7, 2023 | CHEMED CORP (CHE) | Gift | 761 | n/a |
| Oct 26, 2023 | CHEMED CORP (CHE) | Grant/Award | 4,522 | $2.30M |